KALEIGH PRUETT: Open Payments
NPI 1104410703 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$226 in 12 payments from 7 companies in 2025. Trend: 2023 $161 · 2024 $289 · 2025 $226
Food & beverage: $226
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $69 |
| ABBVIE INC. | 2 | $43 |
| Averitas Pharma Inc. | 2 | $33 |
| Globus Medical, Inc. | 1 | $33 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| PFIZER INC. | 1 | $17 |
| Neurocrine BioSciences, Inc. | 1 | $13 |
Products named: QUTENZA, Senza, VRAYLAR, BREZTRI, ZAVZPRET, QULIPTA, INGREZZA.
Industry payments across TX — which companies pay providers there.
